Journal of Clinical Endocrinology & Metabolism, Vol 75, 15-20, Copyright © 1992 by Endocrine Society

ARTICLES

Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells

J Hellmer, C Marcus, T Sonnenfeld and P Arner
Department of Medicine, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden.

Catecholamine-regulation of lipolysis and beta-adrenoceptor binding isoterms were studied in human sc and omental isolated fat cells from 24 subjects undergoing elective cholecystectomy. The lipolytic sensitivity of the nonselective beta-agonists epinephrine and isoprenaline as well as the selective agonists norepinephrine (beta 1) and terbutaline (beta 2) was significantly increased 5-10 times in omental fat cells. On the other hand, no regional difference in antilipolytic sensitivity was seen for the alpha 2 agonist clonidine. No regional difference in lipolytic action was seen when measuring the effect of forskolin, (Bu)2cAMP or enprofylline, which act at different postadrenoceptor steps in the lipolytic cascade. Lipolysis data showed no sex differences. A beta 1-pattern was seen in both regions when lipolysis dose-response curves were arranged in order of potency. Radioligand saturation experiments with the nonselective beta- antagonist 125I-cyanopindolol and competition experiments between this radioligand and the selective antagonists CGP-20,712-A (beta 1) and ICI- 118551 (beta 2) showed a 2-fold increase in the amount of beta 1- and beta 2-adrenergic receptors in omental as compared to sc fat cells (P less than 0.02). Competition studies with the same radioligand and the nonselective beta-agonist isoprenaline showed no regional differences in terms of receptor affinity (Kd high 10 nM and Kd low 1 microM) or in relative fraction of receptors in the high affinity state (35%). It is concluded that an increased lipolytic sensitivity for beta 1- and beta 2-agonists can be due to an increase in the amount of the two adrenoceptor subtypes in omental fat cells and thereby explain why catecholamines are more lipolytic in omental cells than in sc fat cells.

This article has been cited by other articles:

				S. Mori, M. Takizawa, M. Satou, M. Sakasai, H. Kusuoku, H. Nojiri, N. Yoshizuka, M. Hotta, T. Kitahara, T. Hase, et al. Enhancement of Lipolytic Responsiveness of Adipocytes by Novel Plant Extract in Rat Experimental Biology and Medicine, December 1, 2009; 234(12): 1445 - 1449. [Abstract] [Full Text] [PDF]

				M.-K. Kim, T. Tomita, M.-J. Kim, H. Sasai, S. Maeda, and K. Tanaka Aerobic exercise training reduces epicardial fat in obese men J Appl Physiol, January 1, 2009; 106(1): 5 - 11. [Abstract] [Full Text] [PDF]

				M. Ryden, J. Jocken, V. van Harmelen, A. Dicker, J. Hoffstedt, M. Wiren, L. Blomqvist, A. Mairal, D. Langin, E. Blaak, et al. Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1847 - E1855. [Abstract] [Full Text] [PDF]

				J. Laurencikiene, V. van Harmelen, E. Arvidsson Nordstrom, A. Dicker, L. Blomqvist, E. Naslund, D. Langin, P. Arner, and M. Ryden NF-{kappa}B is important for TNF-{alpha}-induced lipolysis in human adipocytes J. Lipid Res., May 1, 2007; 48(5): 1069 - 1077. [Abstract] [Full Text] [PDF]

				A. Tchernof, C. Belanger, A.-S. Morisset, C. Richard, J. Mailloux, P. Laberge, and P. Dupont Regional differences in adipose tissue metabolism in women: minor effect of obesity and body fat distribution. Diabetes, May 1, 2006; 55(5): 1353 - 1360. [Abstract] [Full Text] [PDF]

				E. A. Nordstrom, M. Ryden, E. C. Backlund, I. Dahlman, M. Kaaman, L. Blomqvist, B. Cannon, J. Nedergaard, and P. Arner A Human-Specific Role of Cell Death-Inducing DFFA (DNA Fragmentation Factor-{alpha})-Like Effector A (CIDEA) in Adipocyte Lipolysis and Obesity Diabetes, June 1, 2005; 54(6): 1726 - 1734. [Abstract] [Full Text] [PDF]

				T. Tchkonia, Y. D. Tchoukalova, N. Giorgadze, T. Pirtskhalava, I. Karagiannides, R. A. Forse, A. Koo, M. Stevenson, D. Chinnappan, A. Cartwright, et al. Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E267 - E277. [Abstract] [Full Text] [PDF]

				C. Schoelch, J. Kuhlmann, M. Gossel, G. Mueller, C. Neumann-Haefelin, U. Belz, J. Kalisch, G. Biemer-Daub, W. Kramer, H.-P. Juretschke, et al. Characterization of Adenosine-A1 Receptor-Mediated Antilipolysis in Rats by Tissue Microdialysis, 1H-Spectroscopy, and Glucose Clamp Studies Diabetes, July 1, 2004; 53(7): 1920 - 1926. [Abstract] [Full Text] [PDF]

				V. Giusti, C. Verdumo, M. Suter, R. C. Gaillard, P. Burckhardt, and F. Pralong Expression of Peroxisome Proliferator-Activated Receptor-{gamma}1 and Peroxisome Proliferator-Activated Receptor-{gamma}2 in Visceral and Subcutaneous Adipose Tissue of Obese Women Diabetes, July 1, 2003; 52(7): 1673 - 1676. [Abstract] [Full Text] [PDF]

				W. I. Sivitz, S. M. Wayson, M. L. Bayless, L. F. Larson, C. Sinkey, R. S. Bar, and W. G. Haynes Leptin and Body Fat in Type 2 Diabetes and Monodrug Therapy J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1543 - 1553. [Abstract] [Full Text] [PDF]

				L H Enevoldsen, B Stallknecht, J Langfort, L N Petersen, C Holm, T Ploug, and H Galbo The effect of exercise training on hormone-sensitive lipase in rat intra-abdominal adipose tissue and muscle J. Physiol., November 1, 2001; 536(3): 871 - 877. [Abstract] [Full Text] [PDF]

				K. Danadian, V. Lewy, J. J. Janosky, and S. Arslanian Lipolysis in African-American Children: Is It a Metabolic Risk Factor Predisposing to Obesity? J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3022 - 3026. [Abstract] [Full Text] [PDF]

				B. L. Wajchenberg Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome Endocr. Rev., December 1, 2000; 21(6): 697 - 738. [Abstract] [Full Text]

				M. Stumvoll, S. Jacob, H. G. Wahl, B. Hauer, K. Löblein, P. Grauer, R. Becker, M. Nielsen, W. Renn, and H. Häring Suppression of Systemic, Intramuscular, and Subcutaneous Adipose Tissue Lipolysis by Insulin in Humans J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3740 - 3745. [Abstract] [Full Text]

				P. Imbeault, C. Couillard, A. Tremblay, J-P. Després, and P. Mauriège Reduced {alpha}2-adrenergic sensitivity of subcutaneous abdominal adipocytes as a modulator of fasting and postprandial triglyceride levels in men J. Lipid Res., September 1, 2000; 41(9): 1367 - 1375. [Abstract] [Full Text]

				L. H. Enevoldsen, B. Stallknecht, J. D. Fluckey, and H. Galbo Effect of exercise training on in vivo lipolysis in intra-abdominal adipose tissue in rats Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E585 - E592. [Abstract] [Full Text] [PDF]

				P. Mauriège, M. Brochu, D. Prud’homme, A. Tremblay, A. Nadeau, S. Lemieux, and J. P. Després Is Visceral Adiposity a Significant Correlate of Subcutaneous Adipose Cell Lipolysis in Men? J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 736 - 742. [Abstract] [Full Text]

				S. Takano, S. Kanzaki, M. Sato, T. Kubo, and Y. Seino Effect of growth hormone on fatty liver in panhypopituitarism Arch. Dis. Child., June 1, 1997; 76(6): 537 - 538. [Abstract] [Full Text]